Lusutrombopag API Manufacturer in India

Swapnroop Pharma · WHO-GMP Certified · +91 87670 62101

Lusutrombopag API Manufacturer in India

Lusutrombopag is an orally active small-molecule thrombopoietin (TPO) receptor agonist used as an active pharmaceutical ingredient in pharmaceutical formulations for thrombocytopenia. It stimulates TPO receptor signaling and supports platelet production by promoting the growth and maturation of megakaryocytes.

Lusutrombopag has CAS Number 1110766-97-6, molecular formula C29H32Cl2N2O5S, and molecular weight 591.54 g/mol. It is a synthetic, nonpeptide TPO receptor agonist supplied for pharmaceutical formulation and research applications.

Lusutrombopag API Overview

Lusutrombopag interacts with the transmembrane region of the human thrombopoietin receptor. Unlike naturally occurring thrombopoietin, it is a small-molecule compound that activates TPO receptor signaling and promotes the proliferation and differentiation of megakaryocytic progenitor cells.

It is used in pharmaceutical development for products intended to increase platelet counts in patients with thrombocytopenia associated with chronic liver disease who are scheduled for an invasive procedure.

Lusutrombopag Applications

  • Pharmaceutical API manufacturing
  • TPO receptor agonist formulation development
  • Thrombocytopenia treatment formulation development
  • Chronic liver disease-related thrombocytopenia research
  • Hematology pharmaceutical research
  • Drug development and analytical research
  • Pharmaceutical quality-control testing

Mechanism of Action of Lusutrombopag

Lusutrombopag acts as an orally active TPO receptor agonist. It binds to the transmembrane domain of human TPO receptors and activates signaling pathways involved in megakaryocyte proliferation, differentiation and maturation. This results in increased platelet production.

Lusutrombopag API Manufacturer and Supplier

Swapproop Drugs and Pharmaceuticals supports the sourcing and supply of Lusutrombopag API for qualified pharmaceutical manufacturing, formulation development and research requirements.

Lusutrombopag can be evaluated according to applicable customer specifications, validated analytical methods and relevant pharmaceutical quality requirements. Technical documentation, product specifications, Certificate of Analysis and commercial details can be requested according to the intended application.

Why Choose Lusutrombopag API?

  • Well-characterized small-molecule TPO receptor agonist
  • Established pharmaceutical application in thrombocytopenia
  • Suitable for formulation development
  • Defined chemical structure and molecular identity
  • Suitable for hematology and pharmaceutical research
  • Technical and quality documentation support

Detailed Specifications

Parameter Specification
Appearance White to off-white crystalline powder
Identification IR & HPLC compliant
Assay (HPLC) 98.0% – 102.0%
Loss on Drying NMT 1.0%
Residue on Ignition NMT 0.5%
Heavy Metals NMT 20 ppm
Individual Impurity NMT 0.5%
Total Impurities NMT 1.0%
Water Content NMT 1.0%
Get Bulk Quote via WhatsApp